Category: News & Events

Timing of Complete Revascularization in STEMI: Insights From the OPTION–STEMI Trial

RevascularizationAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. This editorial examines the findings of the OPTION–STEMI trial and their implications for the management of patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease.

While current guidelines recommend complete revascularization, the trial investigated whether non-culprit lesions should be treated immediately or in a staged procedure during the same hospital admission. The study found that immediate complete revascularization did not demonstrate non-inferiority compared with staged treatment.

Notably, patients with acute heart failure showed worse outcomes with immediate intervention, suggesting that a staged approach during the index hospitalization may be safer for higher-risk patients. (more…)

Loading

When Surgery Fails: The Role of Transcatheter Closure in Treating Giant Coronary Cameral Fistulas

Giant coronary cameral fistulaeAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. This article describes the successful transcatheter closure of a giant coronary cameral fistula in an infant after two unsuccessful surgical attempts.

The patient, a 4-month-old infant with severe heart failure symptoms, was diagnosed with a large fistula connecting the left anterior descending coronary artery to the right ventricle. After surgical ligation failed due to recanalization and high-flow physiology, clinicians adopted a transcatheter rescue strategy. (more…)

Loading

Transcatheter Tricuspid Valve Intervention Plus Optimized Medical Therapy Versus Optimized Medical Therapy Alone in Tricuspid Regurgitation: A Systematic Review and Meta-Analysis

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  Tricuspid regurgitation (TR) is common and associated with substantial morbidity and mortality. Although optimized medical therapy (OMT) can alleviate symptoms, it may be insufficient in severe cases, and surgical interventions carry considerable procedural risk, limiting their use; consequently, tricuspid transcatheter valve interventions (TTVIs) have emerged as a less invasive alternative. The authors of this article conducted a systematic search of PubMed, Scopus, and Web of Science to identify randomized clinical trials and observational studies comparing TTVI plus OMT versus OMT alone. The primary outcome was all-cause mortality, and secondary outcomes included heart failure (HF) hospitalization and a combined outcome of all-cause mortality and HF hospitalization.

(more…)

Loading

Expanded Use of Transcatheter Aortic Valve Replacement in Patients with Low Surgical Risk

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This commentary reviews the role of transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis who are at low surgical risk. Recent clinical trials show that TAVR provides outcomes comparable to surgical aortic valve replacement (SAVR) over mid-term follow-up, while offering potential benefits such as faster recovery. The authors emphasize that treatment decisions should consider patient age, anatomy, comorbidities, and long-term planning for future valve interventions.

(more…)

Loading

Emerging Novel Biomarkers in Acute Coronary Syndrome Management: Insights and Future Directions

Announcing a new article publication for Cardiovascular Innovations and Applications journal.   Acute coronary syndrome (ACS), a primary manifestation of coronary artery disease (CAD), remains a leading cause of global mortality, particularly in low- and middle-income countries. Despite advances in diagnostics and therapy, accurate early risk stratification of ACS remains challenging. Traditional biomarkers such as cardiac troponins and CK-MB are essential for diagnosis but do not capture the full complexity of disease severity, particularly in cases involving inflammation, endothelial dysfunction and plaque instability. This review highlights emerging evidence regarding the roles of inflammatory cytokines and novel biomarkers in ACS pathophysiology, diagnosis and prognostication.

(more…)

Loading

Burden of Hypertensive Disorders of Pregnancy: A Trend Study from 1990 to 2021 with Risk Factor and Dietary Analysis

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Hypertensive disorders of pregnancy (HDP), the third leading cause of maternal mortality worldwide, account for approximately 16% of all maternal deaths. The incidence and mortality rates of HDP vary across regions.

This study was aimed at examining global trends in HDP prevalence from 1990 to 2021, identifying major risk factors associated with HDP-related mortality, and assessing the influence of dietary habits on HDP risk.

(more…)

Loading

Amino Acid Regulation in Metabolic Heart Disease: Mechanisms and Therapeutic Potential

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  In normal cardiac energy metabolism, 95% of the heart’s energy is provided by mitochondria, and preferences for energy-providing substrates vary at different. However, prolonged metabolic alterations impair cardiac function. Therefore, this study primarily focuses on the relationship between amino acid metabolism and diabetic cardiomyopathy and atherosclerosis.

(more…)

Loading

Sleep Apnea and Arrhythmias: Those Who Cannot Change Their Minds Cannot Change Anything

Announcing a new article publication for Cardiovascular Innovations and Applications journal.   Sleep apnea, a highly prevalent disorder characterized by recurrent episodes of airflow limitation and intermittent hypoxia, has emerged as a significant modifier of cardiovascular risk, particularly in patients with cardiac arrhythmias. Affecting more than half of individuals with atrial fibrillation (AF), sleep apnea contributes to arrhythmogenesis through mechanisms including chronic sympathetic activation, repetitive intrathoracic pressure shifts, hypoxia-driven myocardial remodeling, and autonomic imbalance.

(more…)

Loading

Integrative Mechanisms of Osteoprotegerin in Cardiovascular Pathophysiology

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  Osteoprotegerin (OPG), a glycoprotein in the tumor necrosis factor superfamily, regulates bone metabolism by suppressing the formation and activation of osteoclasts. Nonetheless, increasing evidence underscores its physiological importance, particularly in cardiovascular diseases (CVDs). Elevated OPG levels are associated with atherosclerosis, arterial calcification, and heart failure, thus indicating their involvement in cardiac remodeling and vascular pathology. OPG regulates calcification and vascular homeostasis by restricting the transdifferentiation of vascular smooth muscle cells into osteogenic phenotypes.

(more…)

Loading

Research Advances in the Mechanisms of Pannexin-1 Channels in Cardiovascular Diseases

Pannexin-1Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases (CVDs), a leading global cause of mortality, are characterized by complex pathogenesis involving multifactorial molecular and cellular processes. Pannexin-1 (Panx1), a transmembrane channel protein, facilitates intercellular signaling through regulated release of small molecules such as adenosine triphosphate (ATP), thereby modulating diverse physiological and pathological pathways. This review explores the structural and functional landscape of Panx1, including its physiological roles, post-translational modifications and activation mechanisms. Its contributions to the pathophysiology of myocardial ischemia-reperfusion injury, cardiac remodeling, (more…)

Loading